Hillsborough, CA, United States of America

Mary A Napier

This inventor holds 20 USPTO granted patents and 1 published patent application and 2 EPO patents, primarily in Biopharmaceuticals. Top assignees: Genentech, Inc., Genetech, Inc.. Active years: 1998-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mary A Napier. Retrieved from https://idiyas.com/inventor/mary-a-napier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 1)

% Patents Active = 55.0

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 8.9

ph-index = 9

Forward Citations = 252(Granted Patents)

Company Filing History:

Years Active: 1998-2010

Loading Chart...

Areas of Expertise:

A33 Antigens

Polypeptides

Nucleic Acids

Immunoadhesins

Inflammatory Disorders

Proteoglycans

Fetal Hemoglobin

T-Lymphocytes

Integrins

Soluble Analogues

Complement Disorders

Disease Treatment

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7741056 - Use of A33 antigens and JAM-IT (2010-06-22),

2. 7470771 - Secreted and transmembrane polypeptides and nucleic acids encoding the same (2008-12-30),

3. 7419663 - Treatment of complement-associated disorders (2008-09-02),

4. 7390879 - Secreted and transmembrane polypeptides and nucleic acids encoding the same (2008-06-24),

5. 7317092 - Secreted and transmembrane polypeptides and nucleic acids encoding the same (2008-01-08),

6. 7211400 - Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens (2007-05-01),

7. 7198917 - Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens (2007-04-03),

8. 7196165 - PRO363 polypeptides (2007-03-27),

9. 7192589 - Treatment of inflammatory disorders with STIgMA immunoadhesins (2007-03-20),

10. 7189529 - PRO792 nucleic acids (2007-03-13),

11. 7115713 - Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens (2006-10-03),

12. 7070955 - Secreted and transmembrane polypeptides and nucleic acids encoding the same (2006-07-04),

13. 7056736 - Secreted and transmembrane polypeptides and nucleic acids encoding the same (2006-06-06),

14. 7018837 - Nucleic acids encoding secreted polypeptides that stimulate release of proteoglycans from cartilage (2006-03-28),

15. 6936254 - Method of inducing fetal hemoglobin synthesis (2005-08-30),

Title: The Innovative Journey of Mary A. Napier

Introduction:

Mary A. Napier, a pioneering inventor hailing from Hillsborough, CA, has made significant contributions to the world of technology and innovation. Her passion for creating solutions to everyday problems has led to groundbreaking inventions that have shaped various industries.

Latest Patents:

Mary A. Napier holds several patents in the fields of renewable energy, sustainable agriculture, and healthcare technology. Her most recent patents include a revolutionary solar panel design that increases energy efficiency by 30% and a smart irrigation system that optimizes water usage in agriculture.

Career Highlights:

With over two decades of experience in the tech industry, Mary A. Napier has worked for leading companies such as Silicon Valley Tech Solutions and InnovateX. Her expertise in product development and innovation strategy has been instrumental in launching successful products that have garnered international acclaim.

Collaborations:

Mary A. Napier has collaborated with top researchers and engineers from renowned universities such as Stanford University and MIT. These collaborations have resulted in cutting-edge inventions that have pushed the boundaries of technology and sustainability.

Conclusion:

In conclusion, Mary A. Napier's relentless pursuit of innovation and her dedication to creating a positive impact on society have solidified her reputation as a trailblazing inventor. Her work continues to inspire future generations of inventors to think outside the box and create solutions that shape a better tomorrow.

Profile summary based on public USPTO records.